Robshaw & Julian Associates’s Bristol-Myers Squibb BMY Stock Holding History

Robshaw & Julian Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$553K	Hold	10,000	–	–	0.4%	40
2017 Q1	$544K	Hold	10,000	–	–	0.39%	38
2016 Q4	$584K	Hold	10,000	–	–	0.43%	38
2016 Q3	$539K	Hold	10,000	–	–	0.4%	39
2016 Q2	$736K	Hold	10,000	–	–	0.56%	37
2016 Q1	$639K	Hold	10,000	–	–	0.48%	40
2015 Q4	$688K	Hold	10,000	–	–	0.53%	37
2015 Q3	$592K	Buy	+10,000	New	+$634K	0.5%	33
2014 Q3	–	Sell	-10,000	Closed	-$485K	–	36
2014 Q2	$485K	Hold	10,000	–	–	0.37%	38
2014 Q1	$520K	Hold	10,000	–	–	0.4%	38
2013 Q4	$532K	Hold	10,000	–	–	0.44%	38
2013 Q3	$463K	Buy	+10,000	New	+$439K	0.39%	39

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Robshaw & Julian Associates's BMY Position: Q2 2017 in Review

Robshaw & Julian Associates held its Bristol-Myers Squibb (BMY) position steady in Q2 2017 at 10,000 shares worth $553K. The position accounts for 0.4% of the portfolio, ranked #40.

Robshaw & Julian Associates first reported a position in BMY in Q3 2013 and has held it in 12 quarters since. The position peaked at $736K in Q2 2016. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Robshaw & Julian Associates held 10,000 shares of Bristol-Myers Squibb worth $553K as of Q2 2017.
Robshaw & Julian Associates left its Bristol-Myers Squibb share count unchanged in Q2 2017.
Bristol-Myers Squibb made up 0.4% of Robshaw & Julian Associates's portfolio in Q2 2017, its #40 holding.
Robshaw & Julian Associates first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 12 quarters since.
Robshaw & Julian Associates's Bristol-Myers Squibb position peaked at $736K in Q2 2016.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.